Victrex PLC
01 December 2005
SCHEDULE 5
BLOCKLISTING SIX MONTHLY RETURN
To: Listing Applications
UK Listing Authority
Financial Services Authority
25, The North Colonnade
Canary Wharf
London, E14 5HS
Please ensure the entries on this return are typed
1. Name of company
VICTREX PLC
...............................................................
2. Name of scheme
EMPLOYEE SHARE OPTION SCHEME
...............................................................
3. Period of return:
From 1 June 2005 To 1 December 2005
4. Number and class of share(s) (amount of stock / debt security) not issued
under scheme
972,604
...............................................................
5. Number of shares issued / allotted under scheme during period:
734,265
...............................................................
6. Balance under scheme not yet issued / allotted at end of period
238,339
........................................................
7. Number and class of share(s) (amount of stock / debt securities) originally
listed and the date of admission;
1,200,000 Ordinary shares of 1p each
........................................................
Please confirm total number of shares in issue at the end of the period in order
for us to update our records
81,241,373.
.......................................................
Contact for queries
Name SONYA MOORE
......................................................
Address VICTREX PLC, VICTREX TECHNOLOGY CENTRE, HILLHOUSE INTERNATIONAL,
THORNTON, CLEVELEYS, LANCASHIRE, FY5 4QD.
......................................................
Telephone 01253 897708
.......................................................
Person making the return
Name SONYA MOORE
.......................................................
Position ASSISTANT COMPANY SECRETARY
.......................................................
Signature
.......................................................
The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.